Join
Live feed
·
INSIDERFilingvia Quantisnow
Bellerophon Therapeutics Inc. logo

SEC Form 4: Amin Naseem was granted 84,000 shares, increasing direct ownership by 52% to 244,287 units

ByQuantisnow·Wall Street's wire, on your screen.
BLPH· Bellerophon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLPH (Bellerophon Therapeutics Inc.) and more on Quantisnow.